Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2008

01-09-2008 | Original Paper

RDW as an Additional Marker in Inflammatory Bowel Disease/Undifferentiated Colitis

Authors: Kofi Clarke, Rabindra Sagunarthy, Sheru Kansal

Published in: Digestive Diseases and Sciences | Issue 9/2008

Login to get access

Abstract

Background Anemia is a common complication in inflammatory bowel disease patients. We postulate that the distribution of lesions in Crohn’s disease is more likely than ulcerative colitis to lead to malabsorption as an additional cause of anemia. RDW, a simple and inexpensive test could be an additional differentiating test. Methods and Results Retrospective review of 284 cases of which 156 cases were diagnosed with Crohn’s disease and 128 cases were diagnosed with ulcerative colitis. There was a significant difference in the mean RDW between the Crohn’s and the ulcerative colitis cases (14.9 vs. 14.3, P = .027). Conclusions We conclude there is a statistical significance between the two groups though this may not represent a clinically significant difference. From our analysis we conclude that RDW is statistically significant and with the implementation of a more rigorous study design and analysis of further data RDW may prove to be a clinically effective marker in differentiating Crohn’s disease from ulcerative colitis.
Literature
2.
go back to reference Wilson A, Reyes E, Ofman J (2004) Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med 116(7):44–49CrossRef Wilson A, Reyes E, Ofman J (2004) Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med 116(7):44–49CrossRef
3.
go back to reference Cronin CC, Shanahan F (2001) Anemia in patients with chronic inflammatory bowel disease. Am J Gastroenterol 96(8):2296–2298PubMedCrossRef Cronin CC, Shanahan F (2001) Anemia in patients with chronic inflammatory bowel disease. Am J Gastroenterol 96(8):2296–2298PubMedCrossRef
4.
go back to reference Hendrickson BA, Gokhale R, Cho JH (2002) Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 15(1):79–94PubMedCrossRef Hendrickson BA, Gokhale R, Cho JH (2002) Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 15(1):79–94PubMedCrossRef
5.
go back to reference Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P (2001) Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol 96(3):730–734PubMedCrossRef Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P (2001) Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol 96(3):730–734PubMedCrossRef
6.
go back to reference Zholudev A, Zurakowski D, Young W et al (2004) Serologic testing with ANCA, ASCA and anti-OmpC in children and young adults with Crohn’s disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol 99(11):2235–2241PubMedCrossRef Zholudev A, Zurakowski D, Young W et al (2004) Serologic testing with ANCA, ASCA and anti-OmpC in children and young adults with Crohn’s disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol 99(11):2235–2241PubMedCrossRef
Metadata
Title
RDW as an Additional Marker in Inflammatory Bowel Disease/Undifferentiated Colitis
Authors
Kofi Clarke
Rabindra Sagunarthy
Sheru Kansal
Publication date
01-09-2008
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2008
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-007-0176-8

Other articles of this Issue 9/2008

Digestive Diseases and Sciences 9/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.